0000905718-14-000844.txt : 20141229 0000905718-14-000844.hdr.sgml : 20141225 20141229123419 ACCESSION NUMBER: 0000905718-14-000844 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141229 DATE AS OF CHANGE: 20141229 EFFECTIVENESS DATE: 20141229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dance Biopharm Inc. CENTRAL INDEX KEY: 0001596126 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264234003 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-230924 FILM NUMBER: 141311584 BUSINESS ADDRESS: STREET 1: 150 NORTH HILL DRIVE, SUITE 24 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415-369-9415 MAIL ADDRESS: STREET 1: 150 NORTH HILL DRIVE, SUITE 24 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: Dance Biopharm, Inc. DATE OF NAME CHANGE: 20140108 D 1 primary_doc.xml X0707 D LIVE 0001596126 Dance Biopharm Inc. 150 NORTH HILL DRIVE, SUITE 24 BRISBANE CA CALIFORNIA 94005 415-369-9415 DELAWARE None Dance Biopharm, Inc. Corporation true John S. Patton, Ph.D c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Executive Officer Director Samantha R. Miller c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Executive Officer Director Greg S. Zante c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Executive Officer Lisa E. Porter, M.D. c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Executive Officer Augustine P.Y. Chow, M.D. c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Director Donald D. Huffman c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Director Jay S. Skyler, M.D. c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Director Joseph J. Krivulka c/o Dance Biopharm Inc. 150 North Hill Drive, Suite 24 Brisbane CA CALIFORNIA 94005 Director Adam Stern c/o Aegis Capital Corp. 810 Seventh Ave., 18th Floor New York NY NEW YORK 10019 Director Biotechnology Decline to Disclose 06b false 2014-12-19 false true true true true Units consisting of convertible notes and warrants false 0 Aegis Capital Corp 15007 None None 810 SEVENTH AVENUE, 18TH FLOOR NEW YORK NY NEW YORK 10019 All States false 15000000 5078000 9922000 Includes over-allotment option false 52 1200000 true 0 Assumes maximum offering sold; includes commissions paid pursuant to over-allotment 0 true Some of the proceeds may be used for general working capital purposes which may include payment of salaries and other fees to those listed in Item 3, as more fully set forth in the offering materials. false Dance Biopharm Inc. /s/ John S. Patton Ph.D John S. Patton Ph.D Chief Executive Officer 2014-12-29